BayBio Presents IMPACT Report 2005: 2 Billion Doses Delivered to Patients Annually
SAN FRANCISCO--Nov. 1, 20054, 2005--BayBio today released BayBio:IMPACT 2005, documenting the effect that the Northern California life science industry has on patients' lives everyday:-- More than 240 products on the market are from Northern California saving lives everyday
-- Patients in the U.S. alone have received over 2 billion doses annually from Northern California
-- 200 products are in Phase II/III development in Northern California addressing major unmet medical needs
-- More than a third of all domestic public biotech companies are located in Northern California, representing a collective value of $150 billion and investing close to $4 billion annually in research
-- More companies and employees are focused on life science in Northern California than in any other national or international region
"The life science business is serious and time-consuming requiring massive investment with high risks all around -- when we don't deliver, patients suffer," Bill Young, Chairman & CEO of Monogram Biosciences Inc. (MGRM) and a Member of the Board of BayBio, said. "Northern California's biotech companies have a solid track record of success taking products from the bench to the bedside, and we have only just begun," Dr. Corey Goodman, President & CEO of Renovis Inc. (RNVS) and a Member of the Board of BayBio, added. "If Northern California is to sustain its leadership position and continue to grow in the life science industry, public policy must change at all levels -- from research and development to manufacturing and healthcare delivery," Matt Gardner, President of BayBio, stated. He added: "The regulatory environment can only be improved by government and industry working together. Better government will help us to get cures to patients faster."
The report will be presented to policymakers, media, academia and industry with a discussion of the public policy challenges facing the industry in San Francisco, Calif., on November 14 at 10:00 AM, in Sacramento, Calif., on November 15 at 12:00 noon and in Washington, D.C., on November 17 at 12:00 noon. Further, BayBio will bring these leaders together to discuss pressing issues of concern for patients and industry.
San Francisco, Calif. Sacramento, Calif.
----------------------------------------------------------------------
WHO: -- Matthew Gardner, -- Matthew Gardner,
President, BayBio President, BayBio
-- Dr. Corey Goodman, -- Dr. Corey Goodman,
President & CEO, Renovis President & CEO, Renovis
-- William Young, CEO -- William Young, CEO
Monogram Biosciences Monogram Biosciences
WHEN: Monday, Nov. 14, 2005 Tuesday, Nov. 15, 2005
10:00 AM 12:00 Noon
WHERE: UCSF Mission Bay State Capitol Building
Community Center Eureka Room, Downstairs
1675 Owens Street 10th & L Street
San Francisco, CA 94107 Sacramento, CA 95814
RSVP: jrothschild@baybio.org jrothschild@baybio.org
Washington, D.C.
--------------------------------------------
WHO: -- Anna Eshoo, Congresswomen,
14th District of California
-- Brent Del Monte, VP Federal
Government Relations, BIO
-- Matthew Gardner,
President, BayBio
-- Lori Weiman, VP Public
Affairs, MedImmune
WHEN: Thursday, Nov. 17, 2005
12:00 Noon
WHERE: U.S. Capitol Building
Room HC5
Washington, D.C.
RSVP: biohillevent@bio.org
About BayBio
BayBio is Northern California's life science association. We support the regional bioscience community through advocacy, enterprise support, best practice dissemination and the enhancement of research collaboration. Our members include organizations engaged in, or supportive of, research, development and commercialization of life science technologies.
For more information please visit www.baybio.org or call 650-871-7101.